C Spp Prosthetic Joint Infection clinical trials

Explore recruiting c spp prosthetic joint infection clinical trials.

Also recruiting in Europe

C Spp Prosthetic Joint Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Impact of rifampicin in treatment outcome of Cutibacterium spp. prosthetic joint infections - RIFACute

France

Phase II and Phase III (Integrated) EU CTIS Study details

C Spp Prosthetic Joint Infection trials by city

C Spp Prosthetic Joint Infection in Toronto C Spp Prosthetic Joint Infection in Vancouver C Spp Prosthetic Joint Infection in Montreal C Spp Prosthetic Joint Infection in Calgary C Spp Prosthetic Joint Infection in Edmonton C Spp Prosthetic Joint Infection in Ottawa C Spp Prosthetic Joint Infection in Winnipeg C Spp Prosthetic Joint Infection in Quebec City C Spp Prosthetic Joint Infection in Hamilton C Spp Prosthetic Joint Infection in Kitchener C Spp Prosthetic Joint Infection in London C Spp Prosthetic Joint Infection in Halifax C Spp Prosthetic Joint Infection in New York C Spp Prosthetic Joint Infection in Los Angeles C Spp Prosthetic Joint Infection in Chicago C Spp Prosthetic Joint Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease